These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The role of impaired insulin/IGF action in primary diabetic encephalopathy. Li ZG, Zhang W, Sima AA. Brain Res; 2005 Mar 10; 1037(1-2):12-24. PubMed ID: 15777748 [Abstract] [Full Text] [Related]
10. C-peptide and diabetic encephalopathy. Cai XJ, Xu HQ, Lu Y. Chin Med Sci J; 2011 Jun 04; 26(2):119-25. PubMed ID: 21703121 [Abstract] [Full Text] [Related]
12. Protection of pancreatic beta-cells: is it feasible? Bonora E. Nutr Metab Cardiovasc Dis; 2008 Jan 04; 18(1):74-83. PubMed ID: 18096375 [Abstract] [Full Text] [Related]
13. C-peptide prevents nociceptive sensory neuropathy in type 1 diabetes. Kamiya H, Zhang W, Sima AA. Ann Neurol; 2004 Dec 04; 56(6):827-35. PubMed ID: 15497155 [Abstract] [Full Text] [Related]
14. Cerebral ischemia-induced apoptosis and necrosis in normal and diabetic rats: effects of insulin and C-peptide. Rizk NN, Rafols JA, Dunbar JC. Brain Res; 2006 Jun 22; 1096(1):204-12. PubMed ID: 16729987 [Abstract] [Full Text] [Related]
15. [Diabetic neuropathy]. Chudzik W, Kaczorowska B, Przybyła M, Chudzik B, Gałka M. Pol Merkur Lekarski; 2007 Jan 22; 22(127):66-9. PubMed ID: 17477095 [Abstract] [Full Text] [Related]
20. Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy. Dave GS, Kalia K. Cell Mol Biol (Noisy-le-grand); 2007 May 30; 53(5):68-78. PubMed ID: 17543235 [Abstract] [Full Text] [Related] Page: [Next] [New Search]